Xconomy |  - Business + Technology in the Exponential Economy

From Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner:

Acetylon Pharmaceuticals logo
Acetylon Pharmaceuticals logo

Acetylon is developing targeted HDAC inhibitor drugs.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.